Kun‐Liang Guan

机构：Westlake University, University of California San Diego, Moores Cancer Center · ORCID：0000-0003-1892-0174

发表论文 632 篇 · 总被引 135125 次 · h-index 169

代表论文

• The Hippo pathway: Organ size control and beyond (2024 · Pharmacological Reviews · 被引 42)
• Pathogen-derived glyoxylate inhibits Tet2 DNA dioxygenase to facilitate bacterial persister formation (2025 · Cell Metabolism · 被引 15)
• Functional annotation of the Hippo pathway somatic mutations in human cancers (2024 · Nature Communications · 被引 15)
• Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis (2025 · Science Advances · 被引 10)
• IGF2 mediates Hippo signaling to control liver size (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Nutrient Availability Dictates Cancer Metabolism–Based Therapeutic Responses to Nononcology Drugs (2025 · Cancer Research · 被引 1)